Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Cervical CancerEndometrial Cancer
Trial Locations (1)

000168

Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, UOC Ginecologia Oncologica, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER